Information icon

💚 New Oral Weight Loss Treatment Available | Use Code WL15 🌟

Search Health News

Weight loss pills and alcohol: Can you drink while taking oral GLP-1s?

Bearded man drinking a pint of beer

Most people can drink alcohol while taking new GLP-1 weight loss pills such as the Wegovy tablet or Foundayo (Orforglipron). There isn’t any specific interaction between these medicines and alcohol, so if you’re considering these treatments, you won’t need to give up drinking completely.

But that doesn’t mean alcohol and weight loss pills are the perfect combination.

Some people notice their tolerance drops, while alcohol can also make common side effects like nausea and heartburn worse, may slow your weight loss progress, and, if you’re diabetic, raise the risk of low blood sugar. Others find the desire to drink goes altogether.

Here, we’ll explain everything currently known about alcohol and oral GLP-1 tablets for weight loss, along with some practical tips for drinking safely while you’re taking them.

Please be aware that Orforglipron (Foundayo) has not yet been approved for use in the UK and is awaiting approval by the MHRA. This article is for informational purposes only.

Contact us for advice or complete an online consultation to explore your treatment options.

Discover our range or weight loss tablets that are currently available in the UK.

In this article:

  • Is alcohol safe with oral GLP-1 weight loss pills?

  • How do GLP-1 pills affect how the body responds to alcohol?

  • How does alcohol affect GLP-1 treatment?

  • Are there any times you should avoid alcohol?

  • What does sensible drinking look like on oral GLP-1s?

Is alcohol safe with oral GLP-1 weight loss pills?

Semaglutide (the active ingredient in Wegovy) is not known to have a direct interaction with alcohol. This means there is no official requirement to completely avoid drinking while taking Wegovy pills, and it’s “safe” in this sense.

Equally, while not yet licensed in the UK, Foundayo (Orforglipron) has no indication of interaction with alcohol where it is licensed in the US. This does not mean that there is official guidance in the UK for Orforglipron to be safe with alcohol, but suggests that this may be the case when it is approved for use in the UK.

It is important to remember that alcohol can affect how you feel on treatment, and treatment can affect how your body responds to alcohol. The impact varies from person to person, which is why some people continue to enjoy an occasional drink without any issues, while others find they need to cut back significantly.

If you choose to drink alcohol while taking an oral GLP-1 weight loss medication, it’s generally best to drink in moderation.

How do weight loss pills affect how the body responds to alcohol?

Not everyone taking a GLP-1 weight loss pill will notice a difference in how their body responds to alcohol. But those who do tend to report one of two changes:

  • Feeling the effects of alcohol more quickly. Many GLP-1 users report getting tipsy after fewer drinks than usual. Researchers are still trying to understand why, but recent studies suggest that GLP-1s may slow the breakdown of alcohol in the liver, causing blood alcohol levels to rise higher and stay elevated for longer (1).

  • Losing interest in drinking altogether. In clinical trials, people taking Semaglutide (the active ingredient in Wegovy) reported lower alcohol cravings and consumed less alcohol on average than those taking a placebo (2-3). GLP-1 medications act on parts of the brain involved in reward, cravings, and appetite, which may help explain this influence on drinking behaviour.

While more research is needed, it's sensible to take things slowly the first few times you drink (if you still have the desire to) after starting a weight loss tablet as your alcohol tolerance may have dropped.

How does alcohol affect weight loss tablets?

Although Semaglutide and other GLP-1 tablets don’t directly interact with alcohol, drinking may:

  • Make common digestive side effects worse, such as nausea, vomiting, heartburn, and stomach discomfort. Alcohol can cause many of these symptoms on its own. Combining the two may make GLP-1 side effects more noticeable, particularly when you're first starting a GLP-1 treatment, increasing your dose, or drinking heavily.

  • Increase the risk of low blood sugar. Both alcohol and GLP-1 medications can lower blood sugar levels. For most people taking a GLP-1 for weight loss, this is unlikely to cause any issues. But if you have type 2 diabetes, the combination can sometimes cause blood sugar to drop too low (hypoglycaemia).

  • Make weight loss harder. Alcohol contains calories but not much in terms of nutritional value, and drinking can lower inhibitions and make it easier to reach for high-calorie foods. The occasional drink is unlikely to affect your progress, but regular heavy drinking may make it harder to hit your weight loss goals.

Are there any times you should avoid alcohol when taking weight loss tablets?

This depends on which GLP-1 pill you’re planning to take. Where Foundayo is approved for use (in the US), there is no specific time when alcohol must be completely avoided; this suggests it may be the same when approved in the UK. However, the Wegovy tablet is a little less flexible.

To work properly, the Wegovy tablet must be taken first thing in the morning on an empty stomach with a small amount of water. You then need to wait at least 30 minutes before consuming anything else, including food, coffee, water, other medications — and alcohol (5).

Avoiding alcohol for 30 minutes after taking your tablet is usually straightforward. The bigger issue is often the night before. If you've been drinking heavily or into the early hours, you're more likely to:

  • Wake up dehydrated and reach straight for a large glass of water

  • Forget to take your tablet altogether

  • Struggle to follow the dosing instructions correctly

Late-night drinking can also lead to late-night snacking, meaning you may not have the empty stomach needed for optimal absorption the following morning.

While the occasional night out is unlikely to cause any major problems, regularly letting alcohol disrupt your dosing routine could make treatment less effective. The instructions are there for a reason, so it's important not to let drinking habits interfere with how your medication is absorbed.

What does sensible drinking look like on oral weight loss tablets?

For most people, sensible drinking means keeping alcohol occasional and moderate rather than drinking heavily in one sitting. A good starting point is sticking to one or two drinks and seeing how your body responds. If possible:

  • Avoid drinking on an empty stomach

  • Stay hydrated by alternating alcoholic drinks with water

  • Be cautious with cocktails, beers, and other high-calorie drinks

  • Consider avoiding alcohol during the first few weeks of treatment or after a dose increase if you're experiencing nausea or digestive side effects

  • If you have type 2 diabetes, follow advice from your diabetes team and monitor your blood sugar levels to make sure they don’t drop too low

If you'd like more personalised advice and support on drinking alcohol before starting a GLP-1 medication, our clinical team is here to help. We can also provide guidance on other factors that may affect treatment, including diet, exercise, side effects, and other medications.

Contact us for advice or complete an online consultation to explore your treatment options.

References

  1. Frhaan Zahrawi, Arumugam Suyavaran, Banini BA, Mehal WZ. GLP-1 receptor agonism results in reduction in hepatic ethanol metabolism. npj Metabolic Health and Disease. 2025 Sep 18;3(1):36–6.

  2. Hendershot CS, Bremmer MP, Paladino MB, Kostantinis G, Gilmore TA, Sullivan NR, et al. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder. JAMA Psychiatry [Internet]. 2025 Feb 12;82(4).

  3. Klausen MK, Justesen SK, Pedersen JN, Rasmussen L, Jensen A, Jensen ME, et al. Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial. The Lancet [Internet]. 2026;407(10540):1687–98.

  4. US Food and Drug Administration. Wegovy (Semaglutide) Tablets Prescribing Information. FDA. 2026.